Carsten Niemann (@carsten_niemann) 's Twitter Profile
Carsten Niemann

@carsten_niemann

+10 years hands-on experience in hematology research in Europe and US, heading the CLL research laboratory for precision hematology

ID: 1343221254

linkhttps://www.rigshospitalet.dk/cll-lab calendar_today11-04-2013 01:12:21

71 Tweet

349 Followers

429 Following

NEJM Evidence (@nejmevidence) 's Twitter Profile Photo

In older patients and/or those with comorbidities with untreated #CLL, treatment with ibrutinib-venetoclax was superior to chlorambucil-obinutuzumab, with fewer events and longer PFS after just over 2 yrs of follow-up. Read about the GLOW trial: eviden.cc/3NfZeet #LeuSM

In older patients and/or those with comorbidities with untreated #CLL, treatment with ibrutinib-venetoclax was superior to chlorambucil-obinutuzumab, with fewer events and longer PFS after just over 2 yrs of follow-up. Read about the GLOW trial: eviden.cc/3NfZeet
 
#LeuSM
Carsten Niemann (@carsten_niemann) 's Twitter Profile Photo

CLL patients in general have a mild course of omicron variant COVID, only those with close hospital contacts (due to CLL, comorbidity or COVID) need preventive measures ashpublications.org/blood/article/… #CLL #Covid_19 CLL lab Copenhagen

Carsten Niemann (@carsten_niemann) 's Twitter Profile Photo

First session on machine learning assisted clinical trials - wher to go from here: youtu.be/DQkYLIX9c-g #personalizedmedicine #PrecisionMedicine #clinicaltrials Mihaela van der Schaar CLL lab Copenhagen

Carsten Niemann (@carsten_niemann) 's Twitter Profile Photo

MRD-guided therapy works in CLL - proud to publish together with @ArnonPkater and co-authors the primary analysis of the VISION/HO141 trial in Lancet Oncology: thelancet.com/journals/lanon…

Carsten Niemann (@carsten_niemann) 's Twitter Profile Photo

Individualiseret behandling baseret på måling af restsygdom (MRD) hos patienter med kronisk lymfatisk leukæmi (CLL), tak til patienter og samarbejdspartnere der har gjort dette muligt - rigshospitalet.dk/presse-og-nyt/… CLL lab Copenhagen Rigshospitalet #CLL #PrecisionMedicine

Rigshospitalet (@rigshospitalet) 's Twitter Profile Photo

Patienter med aggressiv leukæmi kan få mere skånsom behandling via måling af sygdomsspor i blodet. Det viser forskning fra overlæge Carsten Utoft Niemann og kolleger i Holland, som netop er offentliggjort i Lancet Oncology. bit.ly/3lYwyuF #dkforsk

Patienter med aggressiv leukæmi kan få mere skånsom behandling via måling af sygdomsspor i blodet. Det viser forskning fra overlæge Carsten Utoft Niemann og kolleger i Holland, som netop er offentliggjort i Lancet Oncology. bit.ly/3lYwyuF #dkforsk
Carsten Niemann (@carsten_niemann) 's Twitter Profile Photo

Next steps introducing decission support for patients with hematological malignancies CLL lab Copenhagen #CLL #PrecisionMedicine healthsciences.ku.dk/newsfaculty-ne…

Carsten Niemann (@carsten_niemann) 's Twitter Profile Photo

Vær med til at forbedre behandlingen for vores patienter - forskningssekretær søges til vores aktive forskningsgruppe: regionh.dk/job/s%C3%B8g-j… Rigshospitalet CLL lab Copenhagen

Carsten Niemann (@carsten_niemann) 's Twitter Profile Photo

Mulighed for at bringe personlig medicin et skridt videre - genopslag af data manager stilling i min forskningsgruppe: candidate.hr-manager.net/ApplicationIni… Rigshospitalet #data #datamanagement #forskning #BigData #MachineLearning

PERSIMUNE (@persimune) 's Twitter Profile Photo

New #PERSIMUNE paper on the gut microbiome in patients with chronic lymphocytic leukaemia is out in Haematologica Read the full article here 👉haematologica.org/article/view/h…

PERSIMUNE (@persimune) 's Twitter Profile Photo

1/2 #PERSIMUNE publication shows how explainable #Artificial_Intelligence can be used to predict personalized survival probabilities in #SARSCOV2 positive patients. This framework can also be used for other diseases. Full article here: nature.com/articles/s4159…

PERSIMUNE (@persimune) 's Twitter Profile Photo

2/2 The project led by Adrian G. Zucco showed that explainable #AI we can not only leverage electronic health records in COVID-19 but also understand specific risk factors and changes through time for each patient moving away from models based on the “average” patient.

2/2 
The project led by <a href="/adrigabzu/">Adrian G. Zucco</a> showed that explainable #AI we can not only leverage electronic health records in COVID-19 but also understand specific risk factors and changes through time for each patient moving away from models based on the “average” patient.
Euraxess Brasil (@euraxessbrasil) 's Twitter Profile Photo

Já pensou em pesquisar na Dinamarca? 🤔🇩🇰 Para saber mais sobre o cenário de pesquisa do país, confira nosso guia: bit.ly/FocusDenmark Também entrevistamos Carsten Niemann, pesquisador dinamarquês sediado no Brasil, para falar da sua experiência 🇧🇷🇩🇰 Clique e saiba mais☝️

Já pensou em pesquisar na Dinamarca? 🤔🇩🇰

Para saber mais sobre o cenário de pesquisa do país, confira nosso guia: bit.ly/FocusDenmark

Também entrevistamos <a href="/carsten_niemann/">Carsten Niemann</a>, pesquisador dinamarquês sediado no Brasil, para falar da sua experiência 🇧🇷🇩🇰

Clique e saiba mais☝️
Carsten Niemann (@carsten_niemann) 's Twitter Profile Photo

Thanks to excellent collaborators turning friends during this 10 year collaboration, thanks to all study teams and a special thanks to all patients and families trusting us developing better treatment for patients with CLL.

Carsten Niemann (@carsten_niemann) 's Twitter Profile Photo

Discussing with #MartinDreyling is always stimulating, so nicely facilitated by #PhilippeRousselot, I think we approached next steps in @datadrivenmedicine. Have a look yourself #EHA2023 CLL lab Copenhagen